[ Price : $8.95]
FDA posts updated guidance outlining how drugmakers should design clinical development programs for new tuberculosis treatments, e...[ Price : $8.95]
FDA delays by three months its decision on Eisai and Biogen's subcutaneous starting-dose formulation of Alzheimers drug Leqembi (l...[ Price : $8.95]
A legal analysis published by Crowell & Moring says a proposed FDA pilot program on artificial intelligence in early-stage clinica...[ Price : $8.95]
President Trump tells reporters he knows nothing about reports suggesting FDA commissioner Marty Makary will be asked to resign so...[ Price : $8.95]
FDA posts new technical guidance document outlining how sponsors should submit continuous glucose monitoring data collected during...[ Price : $8.95]
Boston Scientific begins a Class 1 recall (device correction) involving certain pacemakers and cardiac resynchronization therapy p...[ Price : $8.95]
Several media outlets report that President Trump has signed off on a plan to remove FDA commissioner Marty Makary from his post.[ Price : $8.95]
FDA approves a Partner Therapeutics BLA for Bizengri (zenocutuzumab-zbco) for adults with advanced, unresectable or metastatic cho...